How is PsA diagnosed?

How is PsA diagnosed?

It’s really important to diagnose and treat PsA (psoriatic arthritis) as early as possible. If you don’t, it could cause joint damage.[1] You may first see a GP (General Practitioner) when you notice symptoms you can’t explain.[2] If you’ve already been diagnosed (confirmed) with psoriasis, you probably saw a dermatologist, or skin specialist.[3] If you speak to your GP or dermatologist about joint pain, he or she might refer you to a rheumatologist, or joint specialist.[2][3]

TOP TIP
About 80% of patients who have PsA also have psoriasis, so if you have joint pain, but not Pso, keep an eye on your skin.[4]
diagnosed

There’s no specific test for PsA, but there are certain things your healthcare professional will probably look out for.[5] Firstly, you’ll be assessed and asked about the swelling and pain you’ve noticed.[5] PsA affects quality of life and movement, so you might be questioned about yours.[2][6] Then you might be asked about your family history as you’re more likely to develop it if someone else in your family has it.7 Because the symptoms can be similar to rheumatoid arthritis, you’ll probably have some tests to rule it out, including blood tests.[2] You might also have an X-ray to see whether the swelling and damage is visible.[2]

We’ve put together some tips to help you have a constructive conversation during your appointment, because you should be in control of your PsA and not the other way around.

You may be interested in

Are depression and PsA linked?

You’re twice as likely to suffer from depression if you have PsA than if you only have psoriasis – find out how to handle it.

How to prepare to see your doctor

Make every moment of the consultation really count.

About treatments

Discover what your options might be.

References

National Institute for Clinical Excellence. Psychosis and schizophrenia in adults: prevention and management. 2014. CG178.
APA Clinical Guidelines. American Psychiatric Association. Practice Guidelines for the treatment of patients with schizophrenia. 2004.
Harrigan et al. Psychol Med 2003; 33: 97–110.
Bottlender et al. Schizophr Res 2003; 62: 37–44.
Weiden et al. Psychiatr Serv 2004; 55: 886–891.
Robinson et al. Arch Gen Psychiatry 1999; 56: 241–247.
Logo Janssen | Pharmaceutical Companies of Johnson & Johnson